This compound is primarily utilized in the field of biomedical research, particularly in targeted protein degradation studies. It functions as a key component in PROTAC (Proteolysis Targeting Chimeras) technology, where it aids in the selective degradation of specific proteins within cells. By binding to E3 ubiquitin ligase, it facilitates the tagging of target proteins for proteasomal degradation, offering a powerful tool for understanding protein function and developing potential therapeutic strategies. Its application is especially relevant in cancer research, where it helps in studying oncogenic proteins and exploring novel treatment approaches. Additionally, it is employed in chemical biology to investigate cellular pathways and protein interactions, contributing to the development of innovative drug discovery platforms.